-
October 3, 2023 Lupin Launches Humrahi Unique Patient Support Program for Diabetes Management
-
September 29, 2023 Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 Manufacturing Facility
-
September 28, 2023 Lupin’s Joint Airways Initiative surpasses 10,000 Patients
-
September 22, 2023 Lupin Acquires Five Brands from Menarini
-
September 6, 2023 Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to Expand Access to Medication for COPD Patients
-
August 29, 2023 Lupin Launches Propranolol Long-Acting Capsules to Improve Heart Health in Canada
-
August 29, 2023 Lupin Receives Approval from U.S. FDA for Pirfenidone Capsules
-
August 25, 2023 Lupin Receives Approval from U.S. FDA for Pirfenidone Tablets
-
August 18, 2023 Lupin Acquires Brands ONDERO® and ONDERO MET® to expand Diabetes Portfolio in India
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications